PCSK9 drugs

Coral reef sea underwater

Biotech

Merck dives into data showing PCSK9 pill easily outswims rivals

Merck lifted the lid on the third positive phase 3 trial of its PCSK9 inhibitor, showing the edge the asset has over other oral non-statin therapies.

Nick Paul Taylor Mar 30, 2026 11:45am

Merck Co

Merck's PCSK9 drug mounts injectable-like cholesterol reductions

Nov 10, 2025 10:59am

Coral reef sea underwater

Merck's oral PCSK9 makes waves with 3rd phase 3 win

Sep 2, 2025 9:35am

Coral reef sea underwater

Merck's oral PCSK9 inhibitor leader reduces cholesterol in ph. 3

Jun 9, 2025 9:00am

roadmap hurdles

Verve posts clean PCSK9 editor profile, teeing up Lilly decision

Apr 14, 2025 7:00am

Graphic of someone in a boat navigating the rise and fall of different data riding data plots like a wave

Verve halts VERVE-101 enrollment, focuses on 2nd PCSK9 editor

Apr 2, 2024 7:00am